Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas
- PMID: 23600768
- PMCID: PMC3921010
- DOI: 10.1111/hpb.12094
Jaundice: an important, poorly recognized risk factor for diminished survival in patients with adenocarcinoma of the head of the pancreas
Abstract
Objectives: Jaundice impairs cellular immunity, an important defence against the dissemination of cancer. Jaundice is a common mode of presentation in pancreatic head adenocarcinoma. The purpose of this study was to determine whether there is an association between preoperative jaundice and survival in patients who have undergone resection of such tumours.
Methods: Thirty possible survival risk factors were evaluated in a database of over 400 resected patients. Univariate analysis was used to determine odds ratio for death. All factors for which a P-value of <0.30 was obtained were entered into a multivariate analysis using the Cox model with backward selection.
Results: Preoperative jaundice, age, positive node status, poor differentiation and lymphatic invasion were significant indicators of poor outcome in multivariate analysis. Absence of jaundice was a highly favourable prognostic factor. Interaction emerged between jaundice and nodal status. The benefit conferred by the absence of jaundice was restricted to patients in whom negative node status was present. Five-year overall survival in this group was 66%. Jaundiced patients who underwent preoperative stenting had a survival advantage.
Conclusions: Preoperative jaundice is a negative risk factor in adenocarcinoma of the pancreas. Additional studies are required to determine the exact mechanism for this effect.
© 2013 International Hepato-Pancreato-Biliary Association.
Figures
Comment in
-
Jaundice in resected pancreatic cancer patients.HPB (Oxford). 2014 Feb;16(2):195. doi: 10.1111/hpb.12158. HPB (Oxford). 2014. PMID: 24423079 Free PMC article. No abstract available.
References
-
- Senn N. Surgery of the Pancreas. Philadelphia, PA: W. J. Dornan; 1886. Transactions of the American Surgical Association.
-
- Kim R, Tsao R, Tan A, Byrne M, Almhanna K, Lazaryan A, et al. A single institution review of adjuvant therapy outcomes for resectable pancreatic adenocarcinoma: outcome and prognostic indicators. J Gastrointest Surg. 2010;14:1159–1169. - PubMed
-
- Kawarabayashi N, Seki S, Hatsuse K, Takigawa T, Tsujimoto H, Kawabata T, et al. Immunosuppression in the livers of mice with obstructive jaundice participates in their susceptibility to bacterial infection and tumour metastasis. Shock. 2010;33:500–506. - PubMed
-
- Roughneen PT, Didlake R, Kumar SC, Kahan BD, Rowlands BJ. Enhancement of heterotopic cardiac allograft survival by experimental biliary ligation. Transplantation. 1987;43:437–438. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
